QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 dexcom-announced-the-dexcom-g6-continuous-glucose-monitoring-system-is-being-worn-by-astronauts-in-space-as-part-of-the-polaris-dawn-mission

While in orbit, the Polaris Dawn crew will conduct scientific research designed to advance both human health on Earth and our u...

 jim-cramer-doesnt-like-carnival-right-now-royal-caribbean-is-the-one-you-want

Royal Caribbean has "the best systems right now," Jim Cramer says. "It's got the best numbers. It's the one...

 piper-sandler-reiterates-overweight-on-dexcom-maintains-90-price-target

Piper Sandler analyst Matt O'Brien reiterates DexCom (NASDAQ:DXCM) with a Overweight and maintains $90 price target.

 dexcoms-stelo-device-brings-affordable-continuous-glucose-monitoring-to-type-2-diabetes-patients

DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a ...

 reported-earlier-dexcom-announces-stelo-the-first-over-the-counter-glucose-biosensor-in-the-us-is-now-available-for-purchase-without-a-prescription

Available for purchase today at Stelo.com for people in the U.S. 18 and older not using insulinProvides 24/7 powerful and perso...

 stifel-maintains-buy-on-dexcom-raises-price-target-to-100

Stifel analyst Mathew Blackman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $100.

 sp-500-nasdaq-100-snap-8-day-winning-streak-what-triggered-wall-streets-setback-on-tuesday

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the la...

 sp-500-nasdaq-100-mark-seventh-straight-positive-session-strongest-week-since-october-2023-fridays-top-movers

S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positiv...

 jim-cramer-this-energy-stock-is-a-buy-stay-away-from-dexcom

The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is....

 baird-maintains-neutral-on-dexcom-raises-price-target-to-82

Baird analyst Jeff Johnson maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $80 to $82.

 baird-downgrades-dexcom-to-neutral-lowers-price-target-to-80

Baird analyst Jeff Johnson downgrades DexCom (NASDAQ:DXCM) from Outperform to Neutral and lowers the price target from $161 ...

 doordash-and-exact-sciences-are-among-top-10-large-cap-gainers-last-week-july-28-aug-3-are-the-others-in-your-portfolio

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, ...

 jim-cramer-says-this-home-improvement-chain-is-a-buy-ahead-of-fed-rate-cut-cycle-i-would-pick-some-up-tomorrow

Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION